41 related articles for article (PubMed ID: 21456068)
1. Chromosome 8 markers of metastatic prostate cancer in African American men: gain of the MIR151 gene and loss of the NKX3-1 gene.
Barnabas N; Xu L; Savera A; Hou Z; Barrack ER
Prostate; 2011 Jun; 71(8):857-71. PubMed ID: 21456068
[TBL] [Abstract][Full Text] [Related]
2. Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.
Yamoah K; Johnson MH; Choeurng V; Faisal FA; Yousefi K; Haddad Z; Ross AE; Alshalafa M; Den R; Lal P; Feldman M; Dicker AP; Klein EA; Davicioni E; Rebbeck TR; Schaeffer EM
J Clin Oncol; 2015 Sep; 33(25):2789-96. PubMed ID: 26195723
[TBL] [Abstract][Full Text] [Related]
3. Immunologic Assessment of Tumors from a Race-matched Military Cohort Identifies Mast Cell Depletion as a Marker of Prostate Cancer Progression.
Schafer CC; Jiang J; Elsamanoudi S; Nousome D; Young DY; Song Y; Sesterhenn IA; Chesnut GT; Tan SH
Cancer Res Commun; 2023 Aug; 3(8):1423-1434. PubMed ID: 37534375
[TBL] [Abstract][Full Text] [Related]
4. Quantifying Y chromosome loss in primary and metastatic prostate cancer by chromosome painting.
Rajanala SH; Ghale R; Nandakumar S; Chadalavada K; Lee GM; Stopsack KH; Chen Y; Nanjangud GJ; Chakraborty G; Kantoff PW
PLoS One; 2024; 19(4):e0301989. PubMed ID: 38683764
[TBL] [Abstract][Full Text] [Related]
5. The long tail of oncogenic drivers in prostate cancer.
Armenia J; Wankowicz SAM; Liu D; Gao J; Kundra R; Reznik E; Chatila WK; Chakravarty D; Han GC; Coleman I; Montgomery B; Pritchard C; Morrissey C; Barbieri CE; Beltran H; Sboner A; Zafeiriou Z; Miranda S; Bielski CM; Penson AV; Tolonen C; Huang FW; Robinson D; Wu YM; Lonigro R; Garraway LA; Demichelis F; Kantoff PW; Taplin ME; Abida W; Taylor BS; Scher HI; Nelson PS; de Bono JS; Rubin MA; Sawyers CL; Chinnaiyan AM; ; Schultz N; Van Allen EM
Nat Genet; 2018 May; 50(5):645-651. PubMed ID: 29610475
[TBL] [Abstract][Full Text] [Related]
6. ProstaMine: a bioinformatics tool for identifying subtype-specific co-alterations associated with aggressiveness in prostate cancer.
Orman MV; Sreekanth V; Laajala TD; Cramer SD; Costello JC
Front Pharmacol; 2024; 15():1360352. PubMed ID: 38751776
[TBL] [Abstract][Full Text] [Related]
7. Genetic and biological drivers of prostate cancer disparities in Black men.
Gong J; Kim DM; Freeman MR; Kim H; Ellis L; Smith B; Theodorescu D; Posadas E; Figlin R; Bhowmick N; Freedland SJ
Nat Rev Urol; 2024 May; 21(5):274-289. PubMed ID: 37964070
[TBL] [Abstract][Full Text] [Related]
8. Acquired copy number variation in prostate tumours: a review of common somatic copy number alterations, how they are formed and their clinical utility.
O'Malley DE; Raspin K; Melton PE; Burdon KP; Dickinson JL; FitzGerald LM
Br J Cancer; 2024 Feb; 130(3):347-357. PubMed ID: 37945750
[TBL] [Abstract][Full Text] [Related]
9. Precision intervention for prostate cancer: Re-evaluating who is at risk.
Papachristodoulou A; Abate-Shen C
Cancer Lett; 2022 Jul; 538():215709. PubMed ID: 35490919
[TBL] [Abstract][Full Text] [Related]
10. Differential Expression Profile of lncRNA in Glioma Cells and the Effect of lncRNA NKX3-1 on Glioma Cells Through Fem1b/SPDEF Pathway.
Cai Y; Wang M; Cui Y; Tan Z; Jiang Y
Front Oncol; 2021; 11():706863. PubMed ID: 34350121
[TBL] [Abstract][Full Text] [Related]
11. Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.
Dovey ZS; Nair SS; Chakravarty D; Tewari AK
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1340. PubMed ID: 33599076
[TBL] [Abstract][Full Text] [Related]
12. The Impact of African Ancestry on Prostate Cancer Disparities in the Era of Precision Medicine.
Lewis DD; Cropp CD
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33302594
[TBL] [Abstract][Full Text] [Related]
13. miR-27b expression in diagnosis and evaluation prognosis of prostate cancer.
Li T; Sun X; Liu Y
Int J Clin Exp Pathol; 2017; 10(12):11415-11424. PubMed ID: 31966497
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of tumor protein p53 by microRNA-151a-3p induced cell proliferation, migration and invasion in nasopharyngeal carcinoma.
Liu H; Cheng Y; Xu Y; Xu H; Lin Z; Fan J; Lang J
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652456
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms involving prostate cancer racial disparity.
Karakas C; Wang C; Deng F; Huang H; Wang D; Lee P
Am J Clin Exp Urol; 2017; 5(3):34-48. PubMed ID: 29181436
[TBL] [Abstract][Full Text] [Related]
16. miRNAs associated with prostate cancer risk and progression.
Luu HN; Lin HY; Sørensen KD; Ogunwobi OO; Kumar N; Chornokur G; Phelan C; Jones D; Kidd L; Batra J; Yamoah K; Berglund A; Rounbehler RJ; Yang M; Lee SH; Kang N; Kim SJ; Park JY; Di Pietro G
BMC Urol; 2017 Mar; 17(1):18. PubMed ID: 28320379
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer in men of African origin.
McGinley KF; Tay KJ; Moul JW
Nat Rev Urol; 2016 Feb; 13(2):99-107. PubMed ID: 26718455
[TBL] [Abstract][Full Text] [Related]
18. Hypertension-related, calcium-regulated gene (HCaRG/COMMD5) and kidney diseases: HCaRG accelerates tubular repair.
Matsuda H; Hamet P; Tremblay J
J Nephrol; 2014 Aug; 27(4):351-60. PubMed ID: 24515317
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs that affect prostate cancer: emphasis on prostate cancer in African Americans.
Jones J; Grizzle W; Wang H; Yates C
Biotech Histochem; 2013 Oct; 88(7):410-24. PubMed ID: 23901944
[TBL] [Abstract][Full Text] [Related]
20. Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.
Farrell J; Petrovics G; McLeod DG; Srivastava S
Int J Mol Sci; 2013 Jul; 14(8):15510-31. PubMed ID: 23892597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
